The complexity of sphingolipid biosynthesis in the endoplasmic reticulum

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1833, Issue 11, 2013, Pages 2511-2518

  Tidhar, Rotem ^a   Futerman, Anthony H ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Ceramide; Ceramide synthase; Golgi apparatus; Lipid; Sphingolipid; Transmembrane protein

Indexed keywords

ACYL COENZYME A; CERAMIDE; CERAMIDE SYNTHASE; FINGOLIMOD; FUMONISIN B1; GLUCOSYLCERAMIDE; HISTIDINE; INSULIN RECEPTOR; LIPID; PROTEIN KINASE B; SERINE; SERINE PALMITOYLTRANSFERASE; SPHINGOLIPID; SPHINGOMYELIN; UNCLASSIFIED DRUG;

ACYLATION; APOPTOSIS; ARTICLE; BINDING SITE; DOWN REGULATION; ENDOPLASMIC RETICULUM; ENZYME PHOSPHORYLATION; GOLGI COMPLEX; HUMAN; LIPID TRANSPORT; LIPOGENESIS; NONHUMAN; PRIORITY JOURNAL;

CERAMIDE; CERAMIDE SYNTHASE; GOLGI APPARATUS; LIPID; SPHINGOLIPID; TRANSMEMBRANE PROTEIN;

ANIMALS; BIOLOGICAL TRANSPORT; ENDOPLASMIC RETICULUM; GOLGI APPARATUS; HUMANS; SPHINGOLIPIDS;

EID: 84880616651     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2013.04.010     Document Type: Article

References (94)

1. Pagano R.E., Sleight R.G. Defining lipid transport pathways in animal cells. Science 1985, 229:1051-1057.
2. Merrill A.H.J. Sphingolipid and glycosphingolipid metabolic pathways in the era of sphingolipidomics. Chem. Rev. 2011, 111:6387-6422.
3. Pewzner-Jung Y., Ben-Dor S., Futerman A.H. When do Lasses (longevity assurance genes) become CerS (ceramide synthases)?: insights into the regulation of ceramide synthesis. J. Biol. Chem. 2006, 281:25001-25005.
4. Futerman A.H., Riezman H. The ins and outs of sphingolipid synthesis. Trends Cell Biol. 2005, 15:312-318.
5. Fukasawa M., Nishijima M., Hanada K. Genetic evidence for ATP-dependent endoplasmic retiuculum-to-Golgi apparatus trafficking of ceramide for sphingomyelin synthesis in Chinese hamster ovary cells. J. Cell Biol. 1999, 144:673-685.
6. Hanada K., Kumagai K., Yasuda S., Miura Y., Kawano M., Fukasawa M., Nishijima M. Molecular machinery for non-vesicular trafficking of ceramide. Nature 2003, 426:803-809.
7. Futerman A.H., Pagano R.E. Determination of the intracellular sites and topology of glucosylceramide synthesis in rat liver. Biochem. J. 1991, 280(Pt 2):295-302.
8. Merrill A.H., Nixon D.W., Williams R.D. Activities of serine palmitoyltransferase (3-ketosphinganine synthase) in microsomes from different rat tissues. J. Lipid Res. 1985, 26:617-622.
9. Hanada K. Serine palmitoyltransferase, a key enzyme of sphingolipid metabolism. Biochim. Biophys. Acta 2003, 1632:16-30.
10. Lowther J., Naismith J.H., Dunn T.M., Campopiano D.J. Structural, mechanistic and regulatory studies of serine palmitoyltransferase. Biochem. Soc. Trans. 2012, 40:547-554.
11. Eliot A.C., Kirsch J.F. Pyridoxal phosphate enzymes: mechanistic, structural, and evolutionary considerations. Ann. Rev. Biochem. 2004, 73:383-415.
12. Kobayashi S.D., Nagiec M.M. Ceramide/long-chain base phosphate rheostat in Saccharomyces cerevisiae: regulation of ceramide synthesis by Elo3p and Cka2p. Eukaryot. Cell 2003, 2:284-294.
13. Cowart L.A., Hannun Y.A. Selective substrate supply in the regulation of yeast de novo sphingolipid synthesis. J. Biol. Chem. 2007, 282:12330-12340.
14. Yard B.A., Carter L.G., Johnson K.A., Overton I.M., Dorward M., Liu H., McMahon S.A., Oke M., Puech D., Barton G.J., Naismith J.H., Campopiano D.J. The structure of serine palmitoyltransferase; gateway to sphingolipid biosynthesis. J. Mol. Biol. 2007, 370:870-886.
15. Buede R., Rinker S.C., Pinto W.J., Lester R.L., Dickson R.C. Cloning and characterization of LCB1, a Saccharomyces gene required for biosynthesis of the long-chain base component of sphingolipids. J. Bacteriol. 1991, 173:4325-4332.
16. Nagiec M.M., Baltisberger J.A., Wells G.B., Lester R.L., Dickson R.C. The LCB2 gene of Saccharomyces and the related LCB1 gene encode subunits of serine palmitoyltransferase, the initial enzyme in sphingolipid synthesis. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:7899-7902.
17. Hornemann T., Richard S., Rütti M.F., Wei Y., von Eckardstein A. Cloning and initial characterization of a new subunit for mammalian serine-palmitoyltransferase. J. Biol. Chem. 2006, 281:37275-37281.
18. Dietrich C.R., Han G., Chen M., Berg R.H., Dunn T.M., Cahoon E.B. Loss-of-function mutations and inducible RNAi suppression of Arabidopsis LCB2 genes reveal the critical role of sphingolipids in gametophytic and sporophytic cell viability. Plant J. 2008, 54:284-298.
19. Hojjati M.R., Li Z., Jiang X.C. Serine palmitoyl-CoA transferase (SPT) deficiency and sphingolipid levels in mice. Biochim. Biophys. Acta 2005, 1737:44-51.
20. Ohta E., Ohira T., Matsue K., Ikeda Y., Fujii K., Ohwaki K., Osuka S., Hirabayashi Y., Sasaki M. Analysis of development of lesions in mice with serine palmitoyltransferase (SPT) deficiency - Sptlc2 conditional knockout mice. Exp. Anim. 2009, 58:515-524.
21. Lee S.-Y., Kim J.R., Hu Y., Khan R., Kim S.-J., Bharadwaj K.G., Davidson M.M., Choi C.-S., Shin K.-O., Lee Y.-M., Park W.-J., Park I.-S., Jiang X.-C., Goldberg I.J., Park T.-S. Cardiomyocyte specific deficiency of serine palmitoyltransferase subunit 2 reduces ceramide but leads to cardiac dysfunction. J. Biol. Chem. 2012, 287:18429-18439.
22. Gable K., Slife H., Bacikova D., Monaghan E., Dunn T.M. Tsc3p is an 80-amino acid protein associated with serine palmitoyltransferase and required for optimal enzyme activity. J. Biol. Chem. 2000, 275:7597-7603.
23. Han G., Gupta S.D., Gable K., Niranjanakumari S., Moitra P., Eichler F., Brown R.H., Harmon J.M., Dunn T.M. Identification of small subunits of mammalian serine palmitoyltransferase that confer distinct acyl-CoA substrate specificities. Proc. Natl. Acad. Sci. 2009, 106:8186-8191.
24. Hornemann T., Penno A., Rütti M.F., Ernst D., Kivrak-Pfiffner F., Rohrer L., von Eckardstein A. The SPTLC3 subunit of serine palmitoyltransferase generates short chain sphingoid bases. J. Biol. Chem. 2009, 284:26322-26330.
25. Russo S.B., Tidhar R., Futerman A.H., Cowart L.A. Myristate-derived d16:0-sphingolipids constitute a cardiac sphingolipid pool with distinct synthetic routes and functional properties. J. Biol. Chem. 2013.
26. Eichler F.S., Hornemann T., McCampbell A., Kuljis D., Penno A., Vardeh D., Tamrazian E., Garofalo K., Lee H.-J., Kini L., Selig M., Frosch M., Gable K., von Eckardstein A., Woolf C.J., Guan G., Harmon J.M., Dunn T.M., Brown R.H. Overexpression of the wild-type SPT1 subunit lowers desoxysphingolipid levels and rescues the phenotype of HSAN1. J. Neurosci. 2009, 29:14646-14651.
27. Penno A., Reilly M.M., Houlden H., Laurá M., Rentsch K., Niederkofler V., Stoeckli E.T., Nicholson G., Eichler F., Brown R.H., von Eckardstein A., Hornemann T. Hereditary sensory neuropathy type 1 is caused by the accumulation of two neurotoxic sphingolipids. J. Biol. Chem. 2010, 285:11178-11187.
28. Rotthier A., Auer-Grumbach M., Janssens K., Baets J., Penno A., Almeida-Souza L., Van Hoof K., Jacobs A., De Vriendt E., Schlotter-Weigel B., Löscher W., Vondráček P., Seeman P., De Jonghe P., Van Dijck P., Jordanova A., Hornemann T., Timmerman V. Mutations in the SPTLC2 subunit of serine palmitoyltransferase cause hereditary sensory and autonomic neuropathy type I. Am. J. Hum. Genet. 2010, 87:513-522.
29. Gable K., Han G., Monaghan E., Bacikova D., Natarajan M., Williams R., Dunn T.M. Mutations in the yeast LCB1 and LCB2 genes, including those corresponding to the hereditary sensory neuropathy type I mutations, dominantly inactivate serine palmitoyltransferase. J. Biol. Chem. 2002, 277:10194-10200.
30. Bejaoui K., Wu C., Scheffler M.D., Haan G., Ashby P., Wu L., de Jong P., Brown R.H.J. SPTLC1 is mutated in hereditary sensory neuropathy, type 1. Nat. Genet. 2001, 27:261-262.
31. McCampbell A., Truong D., Broom D.C., Allchorne A., Gable K., Cutler R.G., Mattson M.P., Woolf C.J., Frosch M.P., Harmon J.M., Dunn T.M., Brown R.H. Mutant SPTLC1 dominantly inhibits serine palmitoyltransferase activity in vivo and confers an age-dependent neuropathy. Hum. Mol. Genet. 2005, 14:3507-3521.
32. Gable K., Gupta S.D., Han G., Niranjanakumari S., Harmon J.M., Dunn T.M. A disease-causing mutation in the active site of serine palmitoyltransferase causes catalytic promiscuity. J. Biol. Chem. 2010, 285:22846-22852.
33. Garofalo K., Penno A., Schmidt B.P., Lee H.-J., Frosch M.P., von Eckardstein A., Brown R.H., Hornemann T., Eichler F.S. Oral L-serine supplementation reduces production of neurotoxic deoxysphingolipids in mice and humans with hereditary sensory autonomic neuropathy type 1. J. Clin. Invest. 2011, 121:4735-4745.
34. Zitomer N.C., Mitchell T., Voss K.A., Bondy G.S., Pruett S.T., Garnier-Amblard E.C., Liebeskind L.S., Park H., Wang E., Sullards M.C., Merrill A.H.J., Riley R.T. Ceramide synthase inhibition by fumonisin B1 causes accumulation of 1-deoxysphinganine: a novel category of bioactive 1-deoxysphingoid bases and 1-deoxydihydroceramides biosynthesized by mammalian cell lines and animals. J. Biol. Chem. 2009, 284:4786-4795.
35. Pruett S.T., Bushnev A., Hagedorn K., Adiga M., Haynes C.A., Sullards M.C., Liotta D.C., Merrill A.H.J. Biodiversity of sphingoid bases ("sphingosines") and related amino alcohols. J. Lipid Res. 2008, 49:1621-1639.
36. Breslow D.K.E.A. Orm family proteins mediate sphingolipid homeostasis. Nature 2010, 463:1048-1055.
37. Han S., Lone M.A., Schneiter R., Chang A. Orm1 and Orm2 are conserved endoplasmic reticulum membrane proteins regulating lipid homeostasis and protein quality control. Proc. Natl. Acad. Sci. 2010, 107:5851-5856.
38. Venkataraman K., Riebeling C., Bodennec J., Riezman H., Allegood J.C., Sullards M.C., Merrill A.H., Futerman A.H. Upstream of growth and differentiation factor 1 (uog1), a mammalian homolog of the yeast longevity assurance gene 1 (LAG1), regulates N-stearoyl-sphinganine (C18-(dihydro)ceramide) synthesis in a fumonisin B1-independent manner in mammalian cells. J. Biol. Chem. 2002, 277:35642-35649.
39. Riebeling C., Allegood J.C., Wang E., Merrill A.H., Futerman A.H. Two mammalian longevity assurance gene (LAG1) family members, trh1 and trh4, regulate dihydroceramide synthesis using different fatty acyl-CoA donors. J. Biol. Chem. 2003, 278:43452-43459.
40. Mizutani Y., Kihara A., Igarashi Y. Mammalian Lass6 and its related family members regulate synthesis of specific ceramides. Biochem. J. 2005, 390:263.
41. Mizutani Y., Kihara A., Igarashi Y. LASS3 is a testis-specific (dihydro)ceramide synthase with relatively broad substrate specificity. Biochem. J. 2006, 398:531-538.
42. Laviad E.L., Albee L., Pankova-Kholmyansky I., Epstein S., Park H., Merrill A.H., Futerman A.H. Characterization of ceramide synthase 2: tissue distribution, substrate specificity, and inhibition by sphingosine 1-phosphate. J. Biol. Chem. 2008, 283:5677-5684.
43. Levy M., Futerman A.H. Mammalian ceramide synthases. IUBMB Life 2010, 62:347-356.
44. Harrer H., Laviad E.L., Humpf H.-U., Futerman A.H. Identification of N-acyl-fumonisin B1 as new cytotoxic metabolites of fumonisin mycotoxins. Mol. Nutr. Food Res. Mar 2013, 57(3):516-522.
45. Kim H.J., Qiao Q., Toop H.D., Morris J.C., Don A.S. A fluorescent assay for ceramide synthase activity. J. Lipid Res. 2012, 53:1701-1707.
46. Lahiri S., Park H., Laviad E.L., Lu X., Bittman R., Futerman A.H. Ceramide synthesis is modulated by the sphingosine analog FTY720 via a mixture of uncompetitive and noncompetitive inhibition in an Acyl-CoA chain length-dependent manner. J. Biol. Chem. 2009, 284:16090-16098.
47. Kageyama-Yahara N., Riezman H. Transmembrane topology of ceramide synthase in yeast. Biochem. J. 2006, 398:585-593.
48. Hirschberg K., Rodger J., Futerman A.H. The long-chain sphingoid base of sphingolipids is acylated at the cytosolic surface of the endoplasmic reticulum in rat liver. Biochem. J. 1993, 290(Pt 3):751-757.
49. Tidhar R., Ben-Dor S., Wang E., Kelly S., Merrill A.H., Futerman A.H. Acyl chain specificity of ceramide synthases is determined within a region of 150 residues in the Tram-Lag-CLN8 (TLC) domain. J. Biol. Chem. 2012, 287:3197-3206.
50. Laviad E.L., Kelly S., Merrill A.H., Futerman A.H. Modulation of ceramide synthase activity via dimerization. J. Biol. Chem. 2012, 287:21025-21033.
51. Mullen T.D., Hannun Y.A., Obeid L.M. Ceramide synthases at the centre of sphingolipid metabolism and biology. Biochem. J. 2012, 441:789-802.
52. Mesika A., Ben-Dor S., Laviad E.L., Futerman A.H. A new functional motif in Hox domain-containing ceramide synthases: identification of a novel region flanking the Hox and TLC domains essential for activity. J. Biol. Chem. 2007, 282:27366-27373.
53. Venkataraman K., Futerman A.H. Do longevity assurance genes containing Hox domains regulate cell development via ceramide synthesis?. FEBS Lett. 2002, 528:3-4.
54. Liu M., Huang C., Polu S.R., Schneiter R., Chang A. Regulation of sphingolipid synthesis through Orm1 and Orm2 in yeast. J. Cell Sci. 2012, 125:2428-2435.
55. Epstein S., Kirkpatrick C.L., Castillon G.A., Muniz M., Riezman I., David F.P.A., Wollheim C.B., Riezman H. Activation of the unfolded protein response pathway causes ceramide accumulation in yeast and INS-1E insulinoma cells. J. Lipid Res. 2012, 53:412-420.
56. Epstein S., Castillon G.A., Qin Y., Riezman H. An essential function of sphingolipids in yeast cell division. Mol. Microbiol. 2012, 84:1018-1032.
57. Sridevi P., Alexander H., Laviad E.L., Min J., Mesika A., Hannink M., Futerman A.H., Alexander S. Stress-induced ER to Golgi translocation of ceramide synthase 1 is dependent on proteasomal processing. Exp. Cell Res. 2010, 316:78-91.
58. Mesicek J., Lee H., Feldman T., Jiang X., Skobeleva A., Berdyshev E.V., Haimovitz-Friedman A., Fuks Z., Kolesnick R. Ceramide synthases 2, 5, and 6 confer distinct roles in radiation-induced apoptosis in HeLa cells. Cell. Signal. 2010, 22:1300-1307.
59. Pewzner-Jung Y., Park H., Laviad E.L., Silva L.C., Lahiri S., Stiban J., Erez-Roman R., Brügger B., Sachsenheimer T., Wieland F., Prieto M., Merrill A.H., Futerman A.H. A critical role for ceramide synthase 2 in liver homeostasis: I alterations in lipid metabolic pathways. J. Biol. Chem. 2010, 285:10902-10910.
60. Pewzner-Jung Y., Brenner O., Braun S., Laviad E.L., Ben-Dor S., Feldmesser E., Horn-Saban S., Amann-Zalcenstein D., Raanan C., Berkutzki T., Erez-Roman R., Ben David O., Levy M., Holzman D., Park H., Nyska A., Merrill A.H., Futerman A.H. A critical role for ceramide synthase 2 in liver homeostasis: II insights into molecular changes leading to hepatopathy. J. Biol. Chem. 2010, 285:10911-10923.
61. Imgrund S., Hartmann D., Farwanah H., Eckhardt M., Sandhoff R., Degen J., Gieselmann V., Sandhoff K., Willecke K. Adult ceramide synthase 2 (Cers2) deficient mice exhibit myelin sheath defects, cerebellar degeneration and hepatocarcinomas. J. Biol. Chem. 2009, 284:33549-33560.
62. Ginkel C., Hartmann D., vom Dorp K., Zlomuzica A., Farwanah H., Eckhardt M., Sandhoff R., Degen J., Rabionet M., Dere E., Dormann P., Sandhoff K., Willecke K. Ablation of Neuronal Ceramide Synthase 1 in Mice Decreases Ganglioside Levels and Expression of Myelin-associated Glycoprotein in Oligodendrocytes. J. Biol. Chem. 2012, 287:41888-41902.
63. Zhao L., Spassieva S.D., Jucius T.J., Shultz L.D., Shick H.E., Macklin W.B., Hannun Y.A., Obeid L.M., Ackerman S.L. A deficiency of ceramide biosynthesis causes cerebellar Purkinje Cell neurodegeneration and lipofuscin accumulation. PLoS Genet. 2011, 7:e1002063.
64. Jennemann R., Rabionet M., Gorgas K., Epstein S., Dalpke A., Rothermel U., Bayerle A., van der Hoeven F., Imgrund S., Kirsch J., Nickel W., Willecke K., Riezman H., Grone H.J., Sandhoff R. Loss of ceramide synthase 3 causes lethal skin barrier disruption. Hum. Mol. Genet. 2012, 21:586-608.
65. Ben David O., Pewzner-Jung Y., Brenner O., Laviad E.L., Kogot-Levin A., Weissberg I., Biton I.E., Pienik R., Wang E., Kelly S., Alroy J., Raas-Rothschild A., Friedman A., Brügger B., Merrill A.H., Futerman A.H. Encephalopathy caused by ablation of very long acyl chain ceramide synthesis may be largely due to reduced galactosylceramide levels. J. Biol. Chem. 2011, 286:30022-30033.
66. Zigdon H., Kogot-Levin A., Park J.-W., Goldschmidt R., Kelly S., Merrill A.H., Scherz A., Pewzner-Jung Y., Saada A., Futerman A.H. Ablation of ceramide synthase 2 causes chronic oxidative stress due to disruption of the mitochondrial respiratory chain. J. Biol. Chem. Feb 2013, 288(7):4947-4956.
67. Park J.-W., Park W.-J., Kuperman Y., Boura-Halfon S., Pewzner-Jung Y., Futerman A.H. Ablation of very long acyl chain sphingolipids causes hepatic insulin resistance in mice due to altered detergent-resistant membranes. Hepatology Feb 2013, 57(2):525-532.
68. Silva L.C., Ben David O., Pewzner-Jung Y., Laviad E.L., Stiban J., Bandyopadhyay S., Merrill A.H., Prieto M., Futerman A.H. Ablation of ceramide synthase 2 strongly affects biophysical properties of membranes. J. Lipid Res. 2012, 53:430-436.
69. Yurlova L., Kahya N., Aggarwal S., Kaiser H.-J., Chiantia S., Bakhti M., Pewzner-Jung Y., Ben David O., Futerman A.H., Brügger B., Simons M. Self-segregation of myelin membrane lipids in model membranes. Biophys. J. 2011, 101:2713-2720.
70. Becker I., Wang-Eckhardt L., Yaghootfam A., Gieselmann V., Eckhardt M. Differential expression of (dihydro)ceramide synthases in mouse brain: oligodendrocyte-specific expression of CerS2/Lass2. Histochem. Cell Biol. Feb 2008, 129(2):233-241.
71. Eckl K.M., Tidhar R., Thiele H., Oji V., Hausser I., Brodesser S., Preil M.L., Önal-Akan A., Stock F., Muller D., Becker K., Casper R., Nürnberg G., Altmüller J., Nürnberg P., Traupe H., Futerman A.H., Hennies H.C. Impaired Epidermal ceramide synthesis causes autosomal recessive congenital ichthyosis and reveals importance of ceramide acyl chain length. J. Invest. Dermatol. Apr. 2 2013, (in press).
72. Futerman A.H., Stieger B., Hubbard A.L., Pagano R.E. Sphingomyelin synthesis in rat liver occurs predominantly at the cis and medial cisternae of the Golgi apparatus. J. Biol. Chem. 1990, 265:8650-8657.
73. Raya A., Revert F., Navarro S., Saus J. Characterization of a novel type of serine/threonine kinase that specifically phosphorylates the human goodpasture antigen. J. Biol. Chem. 1999, 274:12642-12649.
74. Kudo N., Kumagai K., Tomishige N., Yamaji T., Wakatsuki S., Nishijima M., Hanada K., Kato R. Structural basis for specific lipid recognition by CERT responsible for nonvesicular trafficking of ceramide. Proc. Natl. Acad. Sci. 2008, 105:488-493.
75. Olayioye M.A., Hausser A. Integration of non-vesicular and vesicular transport processes at the Golgi complex by the PKD-CERT network. Biochim. Biophys. Acta 2012, 1821:1096-1103.
76. Chandran S., Machamer C.E. Inactivation of ceramide transfer protein during pro-apoptotic stress by Golgi disassembly and caspase cleavage. Biochem. J. 2012, 442:391-401.
77. Heering J., Weis N., Holeiter M., Neugart F., Staebler A., Fehm T.N., Bischoff A., Schiller J., Duss S., Schmid S., Korte T., Herrmann A., Olayioye M.A. Loss of the ceramide transfer protein augments EGF receptor signaling in breast cancer. Cancer Res. 2012, 72:2855-2866.
78. Derré I., Swiss R., Agaisse H. The lipid transfer protein CERT interacts with the Chlamydia inclusion protein IncD and participates to ER-Chlamydia inclusion membrane contact sites. PLoS Pathog. 2011, 7:e1002092.
79. Amako Y., Syed G.H., Siddiqui A. Protein kinase D negatively regulates hepatitis C virus secretion through phosphorylation of oxysterol-binding protein and ceramide transfer protein. J. Biol. Chem. 2011, 286:11265-11274.
80. Wang X., Rao R.P., Kosakowska-Cholody T., Masood M.A., Southon E., Zhang H., Berthet C., Nagashim K., Veenstra T.K., Tessarollo L., Acharya U., Acharya J.K. Mitochondrial degeneration and not apoptosis is the primary cause of embryonic lethality in ceramide transfer protein mutant mice. J. Cell Biol. 2009, 184:143-158.
81. Mencarelli C., Losen M., Hammels C., De Vry J., Hesselink M.K.C., Steinbusch H.W.M., De Baets M.H., Martinez Martinez P. The ceramide transporter and the Goodpasture antigen binding protein: one protein - one function?. J. Neurochem. Jun 2010, 113(6):1369-1386.
82. Loewen C.J.R., Roy A., Levine T.P. A conserved ER targeting motif in three families of lipid binding proteins and in Opi1p binds VAP. EMBO J. 2003, 22:2025-2035.
83. Soccio R.E., Breslow J.L. StAR-related lipid transfer (START) proteins: mediators of intracellular lipid metabolism. J. Biol. Chem. 2003, 278:22183-22186.
84. Kumagai K., Yasuda S., Okemoto K., Nishijima M., Kobayashi S., Hanada K. CERT mediates intermembrane transfer of various molecular species of ceramides. J. Biol. Chem. 2005, 280:6488-6495.
85. Ahn V.E., Lo E.I., Engel C.K., Chen L., Hwang P.M., Kay L.E., Bishop R.E., Privé G.G. A hydrocarbon ruler measures palmitate in the enzymatic acylation of endotoxin. EMBO J. 2004, 23:2931-2941.
86. Kudo N., Kumagai K., Matsubara R., Kobayashi S., Hanada K., Wakatsuki S., Kato R. Crystal structures of the CERT START domain with inhibitors provide insights into the mechanism of ceramide transfer. J. Mol. Biol. 2010, 396:245-251.
87. Raya A., Revert-Ros F., Martinez-Martinez P., Navarro S., Rosello E., Vieites B., Granero F., Forteza J., Saus J. Goodpasture antigen-binding protein, the kinase that phosphorylates the goodpasture antigen, is an alternatively spliced variant implicated in autoimmune pathogenesis. J. Biol. Chem. 2000, 275:40392-40399.
88. Kawano M., Kumagai K., Nishijima M., Hanada K. Efficient trafficking of ceramide from the endoplasmic reticulum to the Golgi apparatus requires a VAMP-associated protein-interacting FFAT motif of CERT. J. Biol. Chem. 2006, 281:30279-30288.
89. Sugiki T., Takeuchi K., Yamaji T., Takano T., Tokunaga Y., Kumagai K., Hanada K., Takahashi H., Shimada I. Structural basis for the Golgi association by the pleckstrin homology domain of the ceramide trafficking protein (CERT). J. Biol. Chem. 2012, 287:33706-33718.
90. Peretti D., Dahan N., Shimoni E., Hirschberg K., Lev S. Coordinated lipid transfer between the endoplasmic reticulum and the Golgi complex requires the VAP proteins and is essential for Golgi-mediated transport. Mol. Biol. Cell. 2008, 19:3871-3884.
91. Tuuf J., Kjellberg M.A., Molotkovsky J.G., Hanada K., Mattjus P. The intermembrane ceramide transport catalyzed by CERT is sensitive to the lipid environment. Biochim. Biophys. Acta 2011, 1808:229-235.
92. D'Angelo G., Polishchuk E., Tullio G.D., Santoro M., Campli A.D., Godi A., West G., Bielawski J., Chuang C.C., van der Spoel A.C., Platt F.M., Hannun Y.A., Polishchuk R., Mattjus P., De Matteis M.A. Glycosphingolipid synthesis requires FAPP2 transfer of glucosylceramide. Nature 2007, 449:62-67.
93. Miller J.P., Lo R.S., Ben-Hur A., Desmarais C., Stagljar I., Noble W.S., Fields S. Large-scale identification of yeast integral membrane protein interactions. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:12123-12128.
94. Tarassov K., Messier V., Landry C.R., Radinovic S., Serna Molina M.M., Shames I., Malitskaya Y., Vogel J., Bussey H., Michnick S.W. An in vivo map of the yeast protein interactome. Science 2008, 320:1465-1470.